What a great day yesterday at CAR-TCR London! 27 Feb, 2025

Thank you to our panelists for an in-depth conversation on Novel CARs and New Applications – Implications for CMC, Process, and Analytics.

Our CSO Farzin Farzaneh, PhD, and

John Maher, CSO, Leucid Bio

Renaud VAILLANT, CEO, Alaya.bio

Paul S Carter, Sr. Director, MSAT, Quell Therapeutics

CAR-TCR Summit Series Europe, London

25-27 Feb

Contact us to discuss how our viral vector expertise can accelerate your therapy from lab to life. Makis Sigalas, PhD

#CARTCRSummit #CellTherapy #GeneTherapy #AdvancedTherapies

#BiotechInnovation #CGT #CARTCR #CARTCellTherapy #TCRTherapy

#Immunotherapy #CancerResearch 

Florence Buchanan